
VISUALIZATION & COMMUNICATION OF MODELING RESULTS
VIDA
Molecular modeling is more than just generating numbers. It is about understanding, rationalizing, predicting, and, most importantly, communicating results. Ultimately, modeling efforts are pointless if they don't influence the target audience. To maximize impact, the audience itself needs an easy-to-use tool to study the appropriate data without overwhelming detail. VIDA offers this solution.
For more detailed information on VIDA, check out the link below:

Visualizing docking results with VIDA's Grapheme™-enabled spreadsheet.
Features
- Advanced 3D graphics for high quality molecular visualizations
- Robust handling and easy browsing of large molecular data sets
- Chemically aware spreadsheet featuring real-time interaction with 1D (SMILES), 2D, and 3D displays
- Preset, customizable views for docking (FRED) and ligand-based similarity searches (ROCS®, EON)
- Scriptable with Python enabling easy customization and extensibility
- All OpenEye Toolkits can be accessed directly through Python scripting interface
- Telemodeling option that allows for interactive sharing of sessions between multiple users over a network
- PDF export of molecular spreadsheet information for easy off-line analysis and discussion
- Supported on Linux, Windows® and Mac OS
Cadence Announces New Life Sciences Leadership
miniWebinar: Opening up the druggable universe one cryptic pocket at a time
Cocktails & Molecules
Expanding Orion’s Capabilities with AI
miniWebinar: Optimizing lead compounds with efficient binding free energy calculations
miniWebinar: Opening up the druggable universe one cryptic pocket at a time
Cocktails & Molecules
Expanding Orion’s Capabilities with AI
miniWebinar: Optimizing lead compounds with efficient binding free energy calculations
Resources
Glimpse the Future through News, Events, Webinars and more
News
Cadence Announces New Life Sciences Leadership
Cadence Molecular Sciences (OpenEye) (CMS)—a business unit of Cadence Design Systems, Inc. Corporate Vice President, Anthony Nicholls, PhD, has announced his retirement as of January, 2025.
Read now
Webinar
miniWebinar: Opening up the druggable universe one cryptic pocket at a time
In our first miniWEBINAR of 2025 we were talking about a computational workflow to validate difficult-to-drug protein targets in "Opening up the druggable universe one cryptic pocket at a time" session presented by David LeBard, Head of Enhanced Sampling at OpenEye, Cadence Molecular Sciences,
Read now

